Navigation Links
YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
Date:8/19/2007

MISSISSAUGA, ON, Aug. 17 /PRNewswire-FirstCall/ - YM BioSciences Inc. (AMEX:YMI, TSX:YM, AIM:YMBA), an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announces that the information required to be disclosed in accordance with Rule 26 of the AIM Rules for Companies is available in the "Shareholder Information/Rule 26 Disclosures" section on the Company's home page, http://www.ymbiosciences.com.

About YM BioSciences

YM BioSciences Inc. is an oncology company that identifies, develops and commercializes differentiated products for patients worldwide. The Company has two late-stage products: nimotuzumab, a humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR) for which recruitment in a Phase III trial in pediatric glioma has just been completed and which is approved in several countries for treatment of various types of head and neck cancer; and AeroLEF(TM), a proprietary, inhaled-delivery composition of free and liposome-encapsulated fentanyl in development for the treatment of moderate to severe pain, including cancer pain.

This press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment o
'/>"/>

SOURCE YM BioSciences Inc.

Copyright©2007 PR Newswire.

1

GOOD

Page: 1 2

Related biology technology :

1. Perscitus Biosciences secures $250K Commerce loan
2. Wisconsin biosciences rise to the challenge
3. Quintessence Biosciences advances cancer drug
4. Quintessence Biosciences names new president
5. Caden Biosciences may signal critical mass
6. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
7. WARF signs licensing pact with BD Biosciences
8. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
9. State awards QRG Biosciences development grant
10. EMD Biosciences partners with European biotech company
11. Quintessence Biosciences forms cancer therapeutic advisory board

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...stCall/ -- GenVec, Inc. (Nasdaq: GNVC ) today ann... ended September 30, 2009. GenVec reported a net l...e months ended September 30, 2009 compared to a ne...mparable quarter of 2008. For the nine months ende...million ($0.15 per share), compared to a net loss ...
(Date:11/5/2009)...2009 at 4:30 p.m. Eastern Time , BOTHELL, WA ...Genex Pharmaceuticals, Inc. ("OncoGenex" or the "C... financial results for the third quarter and nine ...ompany,s highlights for the third quarter of 2009....the operations of OncoGenex Technologies Inc. ("On...
(Date:11/5/2009)...re-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX ), a...or-based technologies to discover novel flavor ing...pply industries, today provided a corporate update...ter ended September 30, 2009. Revenues were $4.2 ... $4.0 million for the third quarter of 2008, an in...
(Date:11/5/2009)...ion correction experts listed in the Trusted LASIK...recently concluded American Academy of Ophthalmolo...ifornia. Dr. Stephen Brint, MD, Dr. Frederick Frau...Rapoza, MD, Dr. Michael Raizman, MD, Dr. James McC...che, MD, and Dr. Parag Majmudar, MD, all leading v...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9
...derscores Intellect,s Leadership in Immunotherapy ... NEW YORK, Sept. 19 Intellect Neurosciences,Inc. ...mpany focused on,development of disease-modifying ...n of Alzheimer,s disease and related disorders, an...ering chimeric peptide vaccines has,been validated...
...o Develop New Prescription Adult Cough Products Us...Technologies, CHESTER, N.J. and SALT LAKE CITY, S...daq: ARxT ) and Lipocine Inc., a,privately- held,...y,validated proprietary technologies to address ke...y announced that they have entered into a license,...
...s Into License, Commercialization and Supply Agree.... Eastern Time, September 19, ...devus,Pharmaceuticals, Inc. (Nasdaq: IDEV ) today...ugh its acquisition of Esprit Pharma, has obtained...URA(R) XR. In connection with,Allergan,s acquisiti...
Other Biology Technology:Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimer's Vaccine in 19 Countries 2Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimer's Vaccine in 19 Countries 3Adams Respiratory Therapeutics and Lipocine Enter into License and Collaboration Agreement 2Adams Respiratory Therapeutics and Lipocine Enter into License and Collaboration Agreement 3Indevus Announces Allergan as New Partner for SANCTURA Brand 2Indevus Announces Allergan as New Partner for SANCTURA Brand 3Indevus Announces Allergan as New Partner for SANCTURA Brand 4Indevus Announces Allergan as New Partner for SANCTURA Brand 5Indevus Announces Allergan as New Partner for SANCTURA Brand 6
(Date:11/8/2009)...EALTH EDUCATION DESIGNED FOR ADULTS WITH INTELLECT...ES , An Indiana University study involving adul...dults increased their personal health knowledge af... Adults with ID, an internationally accepted term...s of obesity, physical inactivity and preventable ...
(Date:11/6/2009)...DELPHIA (November 06, 2009) The Monell Center and...s of the Beijing International Meeting on Taste an...tion with the CAS, the meeting will be the first i... in China. , Alan Leshner, Chief Executive Offic...ience and Executive Publisher of Science magazine,...
(Date:11/4/2009)...ADS: (top news in natural science) , United St... uses less water today than it did 35 years ago, d...in water use are partly attributable to alternativ...nt irrigation systems. According to the latest USG...in the United States goes to cooling thermoelectri...
Breaking Biology News(10 mins):Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Monell Center joins with CAS to host Beijing meeting on taste and smell research 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Eight Miami Area Residents Charged in 2422 Million Medicare Fraud Scheme Involving Home Health Care Agencies 50171 1Eight Miami Area Residents Charged in 2422 Million Medicare Fraud Scheme Involving Home Health Care Agencies 50171 2Eight Miami Area Residents Charged in 2422 Million Medicare Fraud Scheme Involving Home Health Care Agencies 50171 3Eight Miami Area Residents Charged in 2422 Million Medicare Fraud Scheme Involving Home Health Care Agencies 50171 4LSUHSC research identifies enzyme that makes survival molecule for key vision cells 50167 1LSUHSC research identifies enzyme that makes survival molecule for key vision cells 50167 2T STAR grant funds genetic studies on shrimp and papaya and endangered cycad rescue 9016 1T STAR grant funds genetic studies on shrimp and papaya and endangered cycad rescue 9016 2
...fish that belongs to the oldest living family of j...an. , This discovery, published in the March 200...ts, understanding of how color vision evolved in e...f evolution. , "It was unexpected that a ,primit...tential for color vision like humans. The discover...
... Bernard Madoff Ponzi scheme led to the collapse o...ife science research, many bioindustry observers v...uence in the larger economic picture, reports Gen... look at the Madoff factor as representing only on... has been rocked by declining stock prices, additi...
...ation for Dental Research (IADR) has selected Dr. ...chusetts, USA, as the 2009 recipient of the Pharma... award will be presented at the IADR 87th General ...ril 1, 2009,Dr. Papas is the Erling Johansen Profe...partment of General Dentistry at the,Tufts Univers...
Other Biology News:Elephant shark genome sequence leads to discovery of color perception in deep-sea fish 2GEN reports on Madoff scandal's impact on the life sciences 2Tufts University professor receives IADR Pharmacology/Therapeutics/Toxicology Award 2
...ilencing experiments often call for critical, but ...oFX Transfection Agent refines siRNA transfection ...eoFXs lipid-based formulation can be used to effic...tured without increased cytotoxicity. From start ...
Kit for BASE20/50 dual control unit KIT50EHTD from Wave Biotech now part of GE Healthcare
...EMICON® CaspaTag™ Pan-Caspase In Situ As... of active caspases in cells undergoing apoptosis....diagnostic or therapeutic procedures. CHEMICON®...use a novel approach to detect active caspases. Th...
jetSI conc. 10 mM from Polyplus Transfection
Biology Products: